Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
収録刊行物
-
- The Lancet
-
The Lancet 396 (10253), 759-769, 2020-09
Elsevier BV